LpxC Inhibitors for Gram-Negative Infections
Treatment of multidrug-resistant bacterial infections with LpxC inhibitors for reduced drug resistance and improved safety profiles
RSS.HDBackground> Background: <
Infection by Gram‑negative bacteria such as Pseudomonas aeruginosa, β‑lactamase producing (ESBL) Enterobacteriaceae, and Acinetobacter baumannii is a major health problem, especially...
Published: 3/19/2025
|
Inventor(s): Peter Tonge, Fereidoon Daryaee, Sneha Basak
Keywords(s):
Category(s): Technology Classifications > Drug Design and/or Synthesis, Technology Classifications > Therapeutics, Campus > Stony Brook University
|